Thermo Fisher Scientific Inc. | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,279
1,896
1,980
2,025
2,228
2,938
Depreciation, Depletion & Amortization
1,000
1,685
1,688
1,758
2,033
2,267
Other Funds
31
57
58
40
3
287
Funds from Operations
1,890
2,452
3,254
3,383
3,511
5,113
Changes in Working Capital
121
168
437
227
494
570
Net Operating Cash Flow
2,011
2,620
2,817
3,156
4,005
4,543
Capital Expenditures
282
428
423
444
508
Sale of Fixed Assets & Businesses
21
1,571
18
26
7
Purchase/Sale of Investments
8
137
18
80
22
Net Investing Cash Flow
263
11,783
1,087
5,532
7,729
Cash Dividends Paid - Total
216
235
241
238
237
Issuance/Reduction of Debt, Net
3,355
1,876
1,933
4,174
3,026
Net Financing Cash Flow
3,310
4,796
2,491
2,861
3,854
Net Change in Cash
5,020
4,483
891
334
550
Free Cash Flow
1,728
2,192
2,394
2,712
3,497
Deferred Taxes & Investment Tax Credit
473
622
525
620
1,098
379
Net Assets from Acquisitions
11
13,060
695
5,188
7,226
Change in Capital Stock
141
3,097
376
1,115
1,068
Exchange Rate Effect
37
116
130
151
420
About Thermo Fisher Scientific
View Profile
